Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066209
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2003-08-05
Brief Title:
Investigating Severe Acute Respiratory Syndrome SARS
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
An Investigation of the Inflammatory Response in Severe Acute Respiratory Syndrome SARS
Status:
COMPLETED
Status Verified Date:
2007-05-24
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Severe Acute Respiratory Syndrome SARS is a newly recognized illness that can be fatal
The purpose of this study is to better understand SARS by collecting samples of blood and other body fluids of people who have been exposed to SARS or who are suspected to have the illness
Up to 300 volunteers aged 18 years or older will be enrolled in this study Participants will donate blood samples and if appropriate samples of fluid from the lungs nose or throat Researchers will test these samples for proteins that control or mediate inflammatory or immune responses The patterns of these proteins will reveal how SARS affects the body and the efforts the body makes to fight off the infection
The purpose of this study is to better understand SARS by collecting samples of blood and other body fluids of people who have been exposed to SARS or who are suspected to have the illness
Up to 300 volunteers aged 18 years or older will be enrolled in this study Participants will donate blood samples and if appropriate samples of fluid from the lungs nose or throat Researchers will test these samples for proteins that control or mediate inflammatory or immune responses The patterns of these proteins will reveal how SARS affects the body and the efforts the body makes to fight off the infection
Detailed Description:
Severe acute respiratory syndrome SARS is a newly recognized illness associated with substantial mobidity and mortality Patients develop fever followed by rapidly progressive and even fatal respiratory disease SARS is associated with infection with a novel coronavirus The evaluation of the inflammatory responses evoked by SARS may yield information regarding its pathogenesis and help with patient management This protocol then merely aims to study disease pathogenesis and natural history by studying samples and data that are collected by outside physicians or physicians at the Clinical Center and sent for evaluation of the inflammatory response
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 03-I-0240 | None | None | None |